Scaling up Multi-party Computation, Data Anonymisation Techniques, and Synthetic Data Generation

Deadline: 21-Apr-22

The European Commission (EC) is seeking proposals for Scaling up Multi-party Computation, Data Anonymisation Techniques, and Synthetic Data Generation to speed up and facilitate innovations in the field of data-driven tools and services for wellbeing, prevention, diagnosis, treatment and follow-up of care, among others.

• Consolidate and scale up multi-party computation and data anonymisation techniques and synthetic data generation to support health technology providers, in particular SMEs.
• Support the development of innovative unbiased AI based and distributed tools, technologies and digital solutions for the benefit of researchers, patients and providers of health services, while maintaining a high level of data privacy.
• Advance the state-of-the-art of de-identification techniques, to tackle the challenge of anonymised datasets that can be traced back to individuals.
• Develop innovative anonymisation techniques demonstrating that effective data quality and usefulness can be preserved without compromising privacy.
• Explore and develop further the techniques of creating synthetic data, also dynamically on demand for specific use cases.
• Widen the basis for GDPR-compliant research and innovation on health data.
• Ensure wide uptake and scalability of the methodologies and tools developed, promote high standards of transparency and openness, going well beyond documentation and extending to aspects such as assumptions, architecture, code and any underlying data.

• public bodies (entities established as a public body under national law, including local, regional or national authorities) or international organisations; and
• cases where the individual requested grant amount is not more than EUR 60 000 (lowvalue grant).

• The EU contributes strongly to global standards for health data through enhancement of common European standards for health data (including medical imaging data) by researchers and innovators. Researchers and innovators contribute to GDPR compliant guidelines and rules for data anonymisation.
• Innovators have access to advanced secure data processing tools to test and develop robust data-driven digital solutions and services in response to the needs of researchers, clinicians and health systems at large.
• Cross-border health data hubs further facilitate the innovation process by providing secure, trustable testing environments for innovators.
• Clinicians, patients and individuals use a larger variety of high quality data tools and services for wellbeing, prevention, diagnosis, treatment and follow-up of care.
• Researchers and innovators have more opportunities for testing and developing GDPR compliant data driven solutions based on actual needs of the health care environments.

• the Member States of the European Union, including their outermost regions;
• the Overseas Countries and Territories (OCTs) linked to the Member States;
• eligible non-EU countries:
  • countries associated to Horizon Europe;
  • low- and middle-income countries.

For more information, visit https://bit.ly/3mseKrG